Developing Therapeutics That Teach the Body to Heal Itself
The Groundbreaking Series Features Engaging Conversations with People Living with HIV, Advocates and Medical Experts Striving Toward the Shared Goal of Ending HIV “The Cure Chronicles,” an innovative video... [Read More]...
American Gene™ founder recognized as one of the field’s most dynamic leaders. Jeff Galvin, CEO and founder of American Gene Technologies®, a clinical-stage biotechnology company based in Rockville, Maryland, has... [Read More]...
American Gene™ Plans for Phase 2 Trial of AGT103-T American Gene Technologies®, a clinical-stage biotechnology company based in Rockville, Maryland, has recorded data that meets the primary and secondary endpoints... [Read More]...
Dr. Marcus Conant Named in UCSF’s Commitment to Pave Way for Next Generation of HIV Researchers American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, congratulates Dr. Marcus... [Read More]...
HIV Clinical Trial Update American Gene Technologies® has completed our Phase 1 clinical trial and we are currently preparing to submit the final report to the FDA. In the meantime,... [Read More]
American Gene Technologies® has recorded data that meets the primary and secondary endpoints of its AGT103-T Phase 1 trial. The Phase 1 trial demonstrated that AGT103-T – an autologous T cell... [Read More]
Clinical Trial Progress Update The analytic treatment interruption (ATI) protocol is generating important immunological data. We are currently gathering and analyzing data from five out of the seven clinical... [Read More]
Exciting HIV Clinical Trial Update American Gene Technologies® HIV Cure Clinical Trial Enters Critical Phase: Withdrawing Participants from Antiretrovirals. “This is a critical step in our mission to cure HIV... [Read More]...
Subscribe to our YouTube Channel Dr. Conant was the first physician to diagnose HIV in San Francisco while running the inpatient dermatology service at the University of California San Francisco.... [Read More]
Subscribe to our YouTube Channel On the heels of Silicon Valley’s branding as one of the world’s largest tech hubs, the BioHealth Capital Region aims to brand the DMV region... [Read More]
Subscribe to our YouTube Channel Mantell Associates Network interviews Jeff Galvin, CEO and Founder of American Gene Technologies™ (AGT) for its global Podcast listeners. In this interview, Galvin shares the... [Read More]
Subscribe to our YouTube Channel Jeff Galvin, CEO of American Gene Technologies, presents AGT’s latest news at the BIO Digital International Convention 2021. As the first patient in AGT’s Phase... [Read More]
Have a listen. From Lab to Launch by Qualio Marcus A. Conant, MD is the Chief Medical Officer at American Gene Technologies. Dr. Conant is a physician who treated thousands... [Read More]
Original post on PharmaVoice.com The company’s using a unique component-based platform to develop functional cures for diseases, including HIV. Welcome to Biotech Spotlight, a series featuring companies that... [Read More]...
Original post on Poz.com By Trent Straube Sexual molestation as a child, an abusive father, the foster care system, violent street gangs, an HIV diagnosis as a teenager. “Anything you can think... [Read More]
The Biotech Project podcast welcomes CEO and Founder of American Gene Technologies®, Jeff Galvin, onto the show to discuss the past, present, and future of the company’s mission to use... [Read More]
Rare disease, as the name suggests, affects a small proportion of the population and appears with low prevalence. The limited number of patients impedes development of new therapies, reducing the... [Read More]
This is a lesson you won’t learn in school. We’re at an exciting stage in biotechnology today, on the cusp of revolutionizing how we treat some of humankind’s most deadly... [Read More]
[1] Contributing Author John Vandermosten, Senior Biotechnology Analyst After a final burst of initial public offerings (IPOs) in early 2021, times have been difficult for life sciences public equities. S&P’s small... [Read More]...
Contributing Author: Kathy Fowler American Gene Technologies® CEO and founder Jeff Galvin was awarded the Life Sciences Voice 2023 Top Industry Leaders Award. The annual award recognizes the most dynamic... [Read More]
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
